albuterol has been researched along with Nasal Polyps in 4 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Nasal Polyps: Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations.
| Excerpt | Relevance | Reference |
|---|---|---|
| " On oral challenges, she developed an urticarial reaction after tartrazine; urticarial and bronchospastic reactions after salicylsalicylic acid; and urticarial and bronchospastic reactions after choline magnesium trisalicylate." | 7.67 | Sensitivity to non-acetylated salicylates in a patient with asthma, nasal polyps, and rheumatoid arthritis. ( Chudwin, DS; Frey, C; Golden, HE; Luskin, AT; Richmond, GW; Strub, M, 1986) |
| " On oral challenges, she developed an urticarial reaction after tartrazine; urticarial and bronchospastic reactions after salicylsalicylic acid; and urticarial and bronchospastic reactions after choline magnesium trisalicylate." | 3.67 | Sensitivity to non-acetylated salicylates in a patient with asthma, nasal polyps, and rheumatoid arthritis. ( Chudwin, DS; Frey, C; Golden, HE; Luskin, AT; Richmond, GW; Strub, M, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fedor, ME | 1 |
| Rubinstein, A | 1 |
| Lacroix, JS | 1 |
| Kurt, AM | 1 |
| Auberson, S | 1 |
| Bretton, C | 1 |
| Sitenga, GL | 1 |
| Ing, EB | 1 |
| Van Dellen, RG | 1 |
| Younge, BR | 1 |
| Leavitt, JA | 1 |
| Chudwin, DS | 1 |
| Strub, M | 1 |
| Golden, HE | 1 |
| Frey, C | 1 |
| Richmond, GW | 1 |
| Luskin, AT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Feasibility and Safety of Immunoglobulin (Ig) Prophylactic Treatment in COPD Patients With Frequent Exacerbations: A Pilot Study[NCT02690038] | Phase 2 | 48 participants (Actual) | Interventional | 2016-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for albuterol and Nasal Polyps
| Article | Year |
|---|---|
Effects of long-term low-dose corticosteroid therapy on humoral immunity.
Topics: Acetates; Agammaglobulinemia; Albuterol; Anti-Asthmatic Agents; Antibodies, Bacterial; Antibody Form | 2006 |
Beta-adrenergic mechanisms in the nasal mucosa vascular bed.
Topics: Adrenergic beta-Antagonists; Adult; Albuterol; Animals; Blood Pressure; Dose-Response Relationship, | 1995 |
Asthma caused by topical application of ketorolac.
Topics: Administration, Topical; Adult; Albuterol; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-S | 1996 |
Sensitivity to non-acetylated salicylates in a patient with asthma, nasal polyps, and rheumatoid arthritis.
Topics: Albuterol; Arthritis, Rheumatoid; Asthma; Bronchial Spasm; Choline; Drug Combinations; Drug Hypersen | 1986 |